🏛️ Congress Orders Cannabis Study • Psychedelics • Debt Restructuring • THC Beverages on Tap

Built by a former cannabis regulator, Policy, Decoded is your high-signal daily briefing for operators, investors, and policymakers navigating the collision of law, regulation, and business.

Today’s edition is supported by The Daily Upside and 1440 Media, two independent reads that keep leaders informed beyond the headlines.

Congress ordered the Alcohol and Tobacco Tax and Trade Bureau to evaluate the “adequacy” of state cannabis frameworks, a move that looks like policy study but functions as regulatory rehearsal. RFK Jr. is leveraging Colorado’s psilocybin program to build the evidence base for a federal medical push. Nebraska regulators imposed restrictive rules that clash with voter intent, California’s Glass House renewed 25 permits despite an expired labor agreement, and operators are turning to Article 9 asset seizures as bankruptcy alternatives. GOP lawmakers want cannabis waivers for military recruits, High Tide’s German deal already faces compliance fire, and our deep dive looks at how THC beverages are moving onto draft lines, colonizing alcohol’s cultural infrastructure as consumption declines.

🏛️ Track Congress’s quiet preparation for federal oversight
💰 Follow restructuring, debt, and capital plays
🍺 Watch cannabis beverages replace alcohol in cultural spaces

Start smarter. Move faster. Stay ahead.

📌 What Happened: House Appropriations Committee directed the Alcohol and Tobacco Tax and Trade Bureau (TTB) and other agencies to assess the "adequacy" of state marijuana regulatory frameworks and provide recommendations to improve federal-state coordination within one year. The committee explicitly acknowledged that "over 20 States and territories now permit the use of adult use cannabis, while over 35 States and territories permit the use of cannabis for medicinal purposes" while simultaneously maintaining longstanding provisions blocking Washington D.C. from using tax dollars to legalize cannabis sales. The study mandate mirrors language from last year's appropriations bills and aligns with House FSGG Appropriations Subcommittee Chairman Dave Joyce's standalone bill directing the attorney general to create a commission for federal legalization recommendations. Separate Labor-HHS appropriations language prohibits agencies from advocating for Schedule 1 drug legalization, with carve-outs for medical evidence and federally sponsored clinical trials.

💡 Why It Matters: The strategic significance lies in federal agencies positioning for cannabis transition while Congress maintains prohibitionist messaging. TTB's lead role in assessing state frameworks is particularly revealing since the bureau would regulate cannabis like alcohol under most federal legalization scenarios, indicating infrastructure preparation beyond academic study. The assessment mandate specifically targets "commonalities and novel approaches to enforcement and oversight," which translates to identifying solutions for the regulatory patchwork crisis federal agencies will inherit - testing standards that vary wildly between states, incompatible labeling requirements, conflicting workplace safety protocols, and trade secret protections that don't cross state lines. The timing coincides with separate appropriations language blocking Justice Department rescheduling efforts while maintaining protections for existing state medical programs, suggesting Congress wants control over cannabis policy rather than executive-driven changes. Multiple agencies receiving "relevant regulatory expertise" mandates indicates broad federal preparation across departments rather than isolated policy review.

🧠 RFK Jr Signals Federal Psychedelic Push Through Colorado Collaboration

Health Secretary RFK Jr. just gave Colorado's Governor Polis the clearest federal green light yet on psychedelics, promising to stay "outspoken" for therapeutic advancement while praising the state's psilocybin program. While everyone fixates on DEA scheduling drama, Kennedy is quietly building a veteran-focused medical pathway that sidesteps traditional regulatory bottlenecks entirely. Colorado's data collection effort becomes the administration's de facto clinical trial - "largest dataset in the history of the world" - giving Kennedy ammunition for medical scheduling arguments within 12 months. The real play here isn't state-federal conflict but strategic alignment: Colorado builds the evidence base, Kennedy delivers federal medical access through VA channels, and both avoid the political minefield of recreational legalization. Smart operators should watch veteran healthcare contracts and therapeutic research partnerships, not ballot initiatives. (Marijuana Moment)

🏛️ Nebraska Cannabis Commission Implements Restrictive Emergency Rules Under Legislative Constraints

Nebraska's Medical Cannabis Commission approved emergency regulations prohibiting flower sales, smoking, and vaping despite voter-approved initiatives explicitly legalizing "all parts of the plant" for medical use. The rules limit dispensaries to one per judicial district and require separate licenses for cultivation, manufacturing, dispensing, and transport, while Gov. Pillen signed the 90-day emergency framework to meet July 1 deadlines. Commission chair Monica Oldenburg defended restrictions saying "everybody says vaping is not medicine" while Commissioner Bruce Bailey pushed back, noting "vaping affects within one to three minutes" for patients needing immediate relief. The commission broke its meeting for an hour-long executive session discussing pending litigation that will "likely come to a head when the body starts doling out licenses". While advocates argue the regulations violate voter intent, the commission appears hamstrung by a hostile legislature and governor who have systematically limited their authority and resources to implement the program voters actually approved. (Nebraska Public Media)

⚖️ Glass House Renewed 25 Cannabis Permits With Expired Labor Agreement

California's largest cannabis cultivator Glass House Brands renewed 25 state permits despite a labor peace agreement that expired in October 2024, exploiting a regulatory loophole with no verification mechanism - just in time for Labor Day weekend. The company submitted attestation claiming its LPA with Seafarers union was still valid, even though union spokesman told WeedWeek "we're completely out of the mix with the cannabis industry and have been for a while". The Department of Cannabis Control operates an essentially automated renewal process where licensees simply check boxes claiming compliance, with "no mechanism in state law for regulators to verify whether that information was correct". This follows Glass House's July ICE raids that arrested 300+ undocumented workers, after which they quickly signed a new LPA with the Teamsters. The real pattern here isn't labor violations but regulatory theater - LPA requirements exist primarily for political optics while enforcement mechanisms remain deliberately toothless, allowing major operators to maintain compliance facades without meaningful oversight. (MJBizDaily)

💰 Cannabis Operators Turn to Article 9 Asset Seizures as Bankruptcy Alternative

Cannabis companies are increasingly using Article 9 secured creditor processes to restructure debt after federal courts continue blocking Chapter 11 filings, with Schwazze surrendering dispensaries to creditors for $65 million cash injection. The senior lenders will take over properties through Article 9, a cheaper and faster process than Chapter 11, since bankruptcy isn't an option due to lack of federal legislation covering cannabis. While the industry faces $6 billion in debt maturing next year, operators are discovering that giving creditors direct asset control actually provides more flexibility than traditional workout negotiations. The real insight here isn't the debt crisis everyone sees coming, but how cannabis companies are pioneering post-bankruptcy restructuring models that other federally restricted industries will likely adopt. Smart money is positioning around distressed asset acquisition opportunities rather than equity plays, since restructurings often wipe out common and preferred shares entirely. (Bloomberg)

🎖️ GOP Lawmakers Push Military Cannabis Waivers Amid Recruitment Crisis

Republican Representatives Dave Joyce and Tony Gonzales filed NDAA amendments expanding marijuana waivers for military recruits and allowing service members to use legal hemp products. Joyce's amendment calls on Air Force, Space Force, and Marine Corps to develop permanent waiver systems like those already used by Army and Navy, acknowledging "ongoing recruitment and retention challenges undermining Armed Forces readiness goals". Gonzales' amendment would prevent the Defense Secretary from prohibiting service members from using hemp products legal under federal, state, and local law, responding to military branch bans on CBD and hemp despite federal legalization. The push comes after last year's House-passed provision to prevent marijuana testing for enlistment was stripped from the final NDAA. While recruitment numbers plummet across all branches, military leadership still maintains zero-tolerance cannabis policies that increasingly conflict with legal state markets and federal hemp law. (Marijuana Moment)

⚖️ High Tide Completes German Cannabis Acquisition Amid Regulatory Compliance Accusations

Canadian retailer High Tide closed its 51% acquisition of German cannabis importer Remexian Pharma on Monday, the same day competitors accused the company of distributing different cannabis cultivars under identical marketing authorization numbers. International law firm Hogan Lovells warned Remexian was allegedly marketing multiple cultivars like "Granddaddy OG, Wonder Punch, Mac Driver, and Shark Attack" all under the same drug name "Madrecan 18/1," violating German Medicines Act requirements for separate approvals. Distribution platform Cansativa immediately dropped Remexian products, citing compliance concerns, while competitor Vayamed demanded a cease and desist declaration by September 1st. High Tide's Omar Khan dismissed the accusations as "administrative interpretation" issues rather than quality concerns, insisting regulatory authorities haven't raised compliance problems. The timing reveals how quickly European cannabis markets can turn on regulatory technicalities - Canadian companies entering these jurisdictions need bulletproof compliance infrastructure, not just market access deals. (StratCann)

🧾 Context: Hemp-derived THC beverages are moving from cans and bottles onto tap lines in Wisconsin, South Carolina, and Minnesota, with companies like Pharos Brands offering 5mg doses through kegs to bars and taverns. Wisconsin establishments including Orsetta in De Pere, Whitetail Inn in St. Germain, and The Phoenix Taproom & Kitchen in Eau Claire have embraced the innovation, while distributor Badger Cannabis reports "tavern operators are finding this to be a potential opportunity as tap lines from beer sit empty". The shift coincides with systematic alcohol industry decline - total beverage alcohol volumes fell 2.8% in the first seven months of 2024, with beer down 3.5%, spirits declining 3%, and wine dropping 4%. The global cannabis beverage market reached $1.3 billion in 2024 and is projected to hit $3.1 billion by 2030, growing at 16.3% annually, while alcohol consumption declined from 62% of Americans in 2023 to 54% currently according to Gallup. Pharos chose Wisconsin precisely because it's "the beer capital of the country" where "bellying up to the bar is such a cultural part of their experience", demonstrating sophisticated market positioning that embeds within existing social rituals.

🔎 What It Signals: Cannabis operators are systematically colonizing America's drinking infrastructure during the most significant alcohol industry contraction in modern history. Non-alcoholic beverage sales spiked 31% to $510 million while functional beverages containing mood enhancers grew 15%, indicating broader consumer migration toward products that provide social lubrication without physiological consequences. Cannabis beverages achieved $54.6 million in Q1 2025 with 15% year-over-year growth despite representing just 1% of total cannabis sales, suggesting massive untapped potential within cannabis markets themselves. More revealing is the geographic arbitrage emerging: emerging markets like Michigan grew 112% and Ohio posted 79% increases while mature cannabis markets like Arizona (-26%) and Colorado (-14%) contracted. Darwin Millard of Cannabis Safety & Quality notes the biggest hurdle remains "stability of emulsions" since cannabinoids aren't water-soluble, yet companies like Rebel Rabbit are solving these challenges with smaller kegs that "can easily be agitated" to restabilize emulsions. Cannabis beverage adoption follows alcohol replacement patterns rather than traditional cannabis adoption curves, creating aligned incentives that accelerate mainstream integration.